[go: up one dir, main page]

RU2018146644A - Композиции на основе каннабидиола и пути их применения - Google Patents

Композиции на основе каннабидиола и пути их применения Download PDF

Info

Publication number
RU2018146644A
RU2018146644A RU2018146644A RU2018146644A RU2018146644A RU 2018146644 A RU2018146644 A RU 2018146644A RU 2018146644 A RU2018146644 A RU 2018146644A RU 2018146644 A RU2018146644 A RU 2018146644A RU 2018146644 A RU2018146644 A RU 2018146644A
Authority
RU
Russia
Prior art keywords
infections
cbd
composition based
composition
sterilizing
Prior art date
Application number
RU2018146644A
Other languages
English (en)
Other versions
RU2018146644A3 (ru
RU2756773C2 (ru
Inventor
Роден ЭШБАХ
Original Assignee
Фармотек Са
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармотек Са filed Critical Фармотек Са
Publication of RU2018146644A publication Critical patent/RU2018146644A/ru
Publication of RU2018146644A3 publication Critical patent/RU2018146644A3/ru
Application granted granted Critical
Publication of RU2756773C2 publication Critical patent/RU2756773C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A01N31/16—Oxygen or sulfur directly attached to an aromatic ring system with two or more oxygen or sulfur atoms directly attached to the same aromatic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/742—Organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B70/00—Preservation of non-alcoholic beverages
    • A23B70/10—Preservation of non-alcoholic beverages by addition of preservatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
    • A23L5/27—Removal of unwanted matter, e.g. deodorisation or detoxification by chemical treatment, by adsorption or by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/381—Microorganisms
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • D—TEXTILES; PAPER
    • D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H21/00—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties
    • D21H21/14—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties characterised by function or properties in or on the paper
    • D21H21/36—Biocidal agents, e.g. fungicidal, bactericidal, insecticidal agents
    • D—TEXTILES; PAPER
    • D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H25/00—After-treatment of paper not provided for in groups D21H17/00 - D21H23/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20—Targets to be treated
    • A61L2202/24—Medical instruments, e.g. endoscopes, catheters, sharps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20—Targets to be treated
    • A61L2202/25—Rooms in buildings, passenger compartments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Birds (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)

Claims (19)

1. CBD или композиция на его основе для применения в предупреждении и/или лечении заболевания, вызванного бактериями P. aeruginosa.
2. CBD или композиция на его основе для применения по п. 1, где указанное заболевание или нарушение выбрано из группы, состоящей из внутрибольничной инфекции, инфекций дыхательных путей, инфекций кожи и мягких тканей, раневых инфекций, зубных и буккальных инфекций, оториноларингологических инфекций, инфекций мочевыводящих и/или предстательных путей, желудочно-кишечных инфекций, инфекции желчевыводящих путей, глазных инфекций, бактериемии, сепсиса, инфекций центральной нервной системы и эндокардита.
3. Применение CBD или композиции на его основе для стерилизации и/или обеззараживания медицинского материала, помещений, предназначенных для медицинской, эстетической или гигиенической практики, или препаратов, предназначенных для использования человеком или в ветеринарии.
4. Применение по п. 3 для обеззараживания или предупреждения загрязнения указанного медицинского материала или препаратов P. aeruginosa.
5. Применение CBD или композиции на его основе по п. 4, где указанный препарат выбран из косметического препарата, пищевого продукта, пищевого препарата и напитка.
6. Применение CBD или композиции на его основе по п. 4 в качестве стерилизующего и/или обеззараживающего средства для медицинских, больничных или чистых помещений.
7. Применение CBD или композиции на его основе по п. 4 в качестве стерилизующего и/или обеззараживающего средства для медицинского материала.
8. Применение CBD или композиции на его основе для консервации произведения искусства.
9. Обеззараживающая или стерилизующая композиция, содержащая CBD в концентрации от приблизительно 0,1 мкг/мл до 200 мг/мл, как например от 0,1 мкг/мл до 1 мг/мл, и дополнительно физиологически приемлемый носитель, разбавитель или вспомогательное вещество.
10. Пищевой продукт, напиток или косметический препарат, содержащий CBD или композицию на его основе в качестве консерванта или стерилизующего средства для указанного препарата в концентрации от приблизительно 0,1 мкг/мл до 200 мг/мл, как например от 0,1 мкг/мл до 1 мг/мл.
11. Изделие, покрытое CBD или композицией на его основе.
12. Набор для обеззараживания или стерилизации поверхности материала или раствора, содержащий CBD или композицию на его основе, и необязательно инструкции по применению.
13. Набор по п. 12, где CBD присутствует в концентрации от приблизительно 0,1 мкг/мл до 200 мг/мл, как например от 0,1 мкг/мл до 1 мг/мл.
14. Способ стерилизации и/или обеззараживания медицинского материала, помещений, предназначенных для медицинской, эстетической или гигиенической практики, или препаратов, предназначенных для применения человеком или в ветеринарии, предусматривающий стадию приведения в контакт указанного материала, помещения или препаратов с CBD или композицией на его основе.
15. Способ ex vivo подавления вирулентности бактерий P. aeruginosa и/или образования биопленки указанными бактериями, причем указанный способ предусматривает стадию приведения в контакт материала или раствора, содержащего указанные бактерии и/или их биопленку, с CBD или композицией на его основе.
16. Способ по п. 15, где композиция на основе CBD представляет собой обеззараживающую или стерилизующую композицию по п. 9.
17. Способ консервации произведения искусства, такого как картины и старинные рукописи, предусматривающий стадию приведения в контакт указанного произведения искусства с CBD или композицией на его основе.
18. Способ по п. 17, где композиция на основе CBD представляет собой обеззараживающую или стерилизующую композицию по п. 9.
19. Способ предупреждения и/или лечения заболевания, вызванного бактериями P. aeruginosa, в частности заболевания или нарушения, выбранного из группы, состоящей из внутрибольничной инфекции, инфекций дыхательных путей, инфекций кожи и мягких тканей, раневых инфекций, зубных и буккальных инфекций, оториноларингологических инфекций, инфекций мочевыводящих и/или предстательных путей, желудочно-кишечных инфекций, инфекции желчевыводящих путей, глазных инфекций, бактериемии, сепсиса, инфекций центральной нервной системы и эндокардита, причем указанный способ включает введение терапевтически эффективного количества CBD или композиции на его основе согласно настоящему изобретению нуждающемуся в этом субъекту.
RU2018146644A 2016-06-02 2017-06-01 Композиции на основе каннабидиола и пути их применения RU2756773C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16172574.2 2016-06-02
EP16172574.2A EP3251668A1 (en) 2016-06-02 2016-06-02 Cannabidiol compositions and uses thereof
PCT/EP2017/063385 WO2017207730A1 (en) 2016-06-02 2017-06-01 Cannabidiol compositions and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2021127368A Division RU2021127368A (ru) 2016-06-02 2017-06-01 Композиции на основе каннабидиола и пути их применения

Publications (3)

Publication Number Publication Date
RU2018146644A true RU2018146644A (ru) 2020-07-09
RU2018146644A3 RU2018146644A3 (ru) 2020-07-30
RU2756773C2 RU2756773C2 (ru) 2021-10-05

Family

ID=56108532

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2021127368A RU2021127368A (ru) 2016-06-02 2017-06-01 Композиции на основе каннабидиола и пути их применения
RU2018146644A RU2756773C2 (ru) 2016-06-02 2017-06-01 Композиции на основе каннабидиола и пути их применения

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RU2021127368A RU2021127368A (ru) 2016-06-02 2017-06-01 Композиции на основе каннабидиола и пути их применения

Country Status (10)

Country Link
US (2) US10952432B2 (ru)
EP (3) EP3251668A1 (ru)
CN (2) CN109640977B (ru)
AU (1) AU2017272795C1 (ru)
CA (1) CA3025850C (ru)
CL (2) CL2018003425A1 (ru)
ES (1) ES2897948T3 (ru)
MX (2) MX388437B (ru)
RU (2) RU2021127368A (ru)
WO (1) WO2017207730A1 (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3251668A1 (en) 2016-06-02 2017-12-06 Pharmotech SA Cannabidiol compositions and uses thereof
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
WO2020000024A1 (en) * 2018-06-28 2020-01-02 Botanix Pharmaceuticals Ltd Antibacterial treatment using cannabinoid combinations
EP3846616A4 (en) * 2018-09-05 2022-05-25 Nemus Bioscience, Inc. CANNABINOIDS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS INCLUDING ANTIBIOTIC RESISTANT BACTERIA STRAINS
WO2020077153A1 (en) 2018-10-10 2020-04-16 Canopy Holdings, LLC Synthesis of cannabigerol
GB2581987B (en) * 2019-03-06 2021-11-17 Gw Res Ltd Use of cannabidiol in combination with antibiotics
EP3986395A4 (en) * 2019-06-18 2023-08-09 Botanix Pharmaceuticals Ltd ANTIBACTERIAL DOSAGE REGIMEN USING CANNABINOIDS
CA3150912A1 (en) * 2019-10-07 2021-04-15 Colgate-Palmolive Company Oral care composition comprising a cannabinoid
CN110973159B (zh) * 2019-10-30 2021-04-06 广州市浪奇实业股份有限公司 一种含有大麻二酚的抗菌组合物及其应用
WO2021102516A1 (en) * 2019-11-29 2021-06-03 Botanix Pharmaceuticals Limited Neisseria treatment using cannabinoids
US20230014447A1 (en) * 2019-11-29 2023-01-19 Botanix Pharmaceuticals Limited Legionella Treatment Using Cannabinoids
AU2020390854A1 (en) * 2019-11-29 2022-06-02 Botanix Pharmaceuticals Limited Moraxella treatment using cannabinoids
CN111150756A (zh) * 2020-01-13 2020-05-15 深圳市麻王爱乐健康科技有限公司 一种治疗前列腺炎的组合物及其制备方法
US20210330603A1 (en) * 2020-02-24 2021-10-28 The Reed Institute Methods of using cannabinoids for inhibiting induction of virulence in enteric pathogens
AU2021232060A1 (en) * 2020-03-05 2022-10-27 University Of Miami Cannabidiol nanodrug formulations and methods for use the same
CN112294709A (zh) * 2020-11-25 2021-02-02 上海英翰进出口有限责任公司 一种具有抗炎、抗氧化功效的免洗凝胶消毒液及其制备方法
CN112891604A (zh) * 2021-01-19 2021-06-04 哈尔滨宝邦生物科技发展有限公司 一种添加cbd涂层的卫生护垫制作工艺
US20220304911A1 (en) * 2021-03-26 2022-09-29 Demetrix, Inc. Oral care product with cannabinoid compounds
DE202021103593U1 (de) * 2021-07-05 2021-08-10 Merlin Apotheke am Hochhaus Ruth Gebhardt & Dr. Frank Ullrich OHG Hautverträgliches, pflegendes und schützendes Mittel zum Auftragen auf die Haut

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6946150B2 (en) 2002-08-14 2005-09-20 Gw Pharma Limited Pharmaceutical formulation
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
US7968594B2 (en) 2005-04-27 2011-06-28 Gw Pharma Limited Pharmaceutical compositions for the treatment of pain
WO2012012498A2 (en) * 2010-07-20 2012-01-26 Pulmatrix, Inc. Use of trp channel agonists to treat infections
FR2965477A1 (fr) * 2010-10-05 2012-04-06 Oreal Utilisation de cannabidiol contre les desequilibres de la microflore cutanee
WO2013009928A1 (en) 2011-07-11 2013-01-17 Organic Medical Research Cannabinoid formulations
EP2804587B1 (en) 2012-01-19 2019-05-08 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Formulation and method for increasing oral bioavailability of drugs
EP3049076A4 (en) * 2013-09-26 2018-04-18 Ronald D. Sekura Topical treatments incorporating cannabis sp. derived botanical drug product
JP6920197B2 (ja) * 2014-06-11 2021-08-18 ポビバ コーポレーションＰｏｖｉｖａ Ｃｏｒｐ． 親油性活性剤を注入された飲食料品組成物とその使用方法
GB2530001B (en) 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
EP3232808B1 (de) 2014-12-19 2020-04-01 THC Pharm GmbH The Health Concept Cbd-haltiges getränk
EP3251668A1 (en) 2016-06-02 2017-12-06 Pharmotech SA Cannabidiol compositions and uses thereof
CN106309401A (zh) 2016-10-14 2017-01-11 杭州惠博士生物科技有限公司 一种用于预防和治疗皮肤疾病的沐浴泡腾片

Also Published As

Publication number Publication date
CN114452282A (zh) 2022-05-10
BR112018074859A2 (pt) 2019-03-26
US10952432B2 (en) 2021-03-23
ES2897948T3 (es) 2022-03-03
RU2018146644A3 (ru) 2020-07-30
MX2021009295A (es) 2021-09-08
AU2017272795B2 (en) 2023-02-02
US20210219547A1 (en) 2021-07-22
AU2017272795C1 (en) 2023-06-08
WO2017207730A1 (en) 2017-12-07
MX388437B (es) 2025-03-19
MX2018014845A (es) 2019-05-06
AU2017272795A1 (en) 2018-12-20
RU2021127368A (ru) 2021-10-15
US20190297882A1 (en) 2019-10-03
CN109640977A (zh) 2019-04-16
CL2018003425A1 (es) 2019-01-18
US11839208B2 (en) 2023-12-12
CL2020001312A1 (es) 2020-08-21
RU2756773C2 (ru) 2021-10-05
EP3463335B1 (en) 2021-08-11
CA3025850C (en) 2024-05-14
EP3942932A1 (en) 2022-01-26
EP3463335A1 (en) 2019-04-10
CA3025850A1 (en) 2017-12-07
CN109640977B (zh) 2022-02-11
EP3251668A1 (en) 2017-12-06

Similar Documents

Publication Publication Date Title
RU2018146644A (ru) Композиции на основе каннабидиола и пути их применения
JP6956143B2 (ja) 抗微生物性組成物とその使用方法
KR101569134B1 (ko) 일산화 이염소 함유 항균 용액, 그의 제조 방법 및 사용 방법
JP2023139074A (ja) 洗浄、消毒および／または滅菌のための組成物、方法および使用
JP2019189613A (ja) 感染を制御するための材料および方法
CN110402084B (zh) 包含乙酸和次氯酸的组合物以及处理生物膜的方法
JP2022506394A (ja) 薬剤耐性を誘導せずにバイオフィルムを処置するための組成物
JP7467445B2 (ja) 一過性バイオフィルムを処置するための組成物および方法
JP5673560B2 (ja) 持続性口腔用殺菌消毒液
US11484549B2 (en) Compositions and methods for treating biofilms without inducing antimicrobial resistance
US11452741B2 (en) Compositions and methods for treating transient biofilms
Khan et al. Anti-microbial efficacy of Allium sativum against Streptococcus mutans biofilm formation on orthodontic mini-implants
JP2015514758A (ja) 長時間持続性表面抗菌剤及び塗布方法
JP7266597B2 (ja) 微生物のコロニー形成を抑制するための置換トラン
JP2013508457A (ja) 感染を制御するための装置、方法、および組成物
Jyoti et al. Ozone in dental therapy: an outlook
JP7211951B2 (ja) バイオフィルムを処置するための酢酸および次亜塩素酸を含む組成物および方法
US20230116077A1 (en) Compositions and methods for treating biofilms without inducing antimicrobial resistance
US20240252530A1 (en) Compositions and methods for treating transient biofilms
Van Zyl et al. Is chlorhexidine mouth rinse, used as a mono-therapy or adjunct with oral hygiene, effective at reducing plaque growth and gingival inflammation?: critical appraisal
JP2013538868A5 (ru)
RASTGAR et al. Silver Sulphadiazine and Fundermol In The Topical Treatment Of Burn Wounds: An Experimental Comparative Study In Rats
RU2021111824A (ru) Композиции летучих органических веществ, обладающие противомикробной активностью
KR20170109812A (ko) 사비넨을 유효성분으로 하는 치면세균막 형성 원인균에 대한 항균 약제용 조성물
JP2006117587A (ja) 殺菌消毒剤組成物